LakeShore Biopharma Co. L... (LSB)
NASDAQ: LSB
· Real-Time Price · USD
1.25
0.05 (4.17%)
At close: May 01, 2025, 2:43 PM
1.25
-0.10%
After-hours: May 01, 2025, 04:37 PM EDT
4.17% (1D)
| Bid | 1.17 |
| Market Cap | 23.85M |
| Revenue (ttm) | 577.33M |
| Net Income (ttm) | -436.09M |
| EPS (ttm) | -2.83 |
| PE Ratio (ttm) | -0.44 |
| Forward PE | 0.85 |
| Analyst | n/a |
| Ask | 1.33 |
| Volume | 3,922 |
| Avg. Volume (20D) | 16,931 |
| Open | 1.23 |
| Previous Close | 1.20 |
| Day's Range | 1.16 - 1.25 |
| 52-Week Range | 1.15 - 11.20 |
| Beta | 0.59 |
About LSB
LakeShore Biopharma Co., Ltd, a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the Uni...
Industry Biotechnology
Sector Healthcare
IPO Date Aug 5, 2021
Employees 758
Stock Exchange NASDAQ
Ticker Symbol LSB
Website https://www.ysbiopharm.com
6 months ago
+21.15%
LakeShore Biopharma shares are trading higher afte...
Unlock content with
Pro Subscription
8 months ago
+2.5%
LakeShore Biopharma shares are trading higher. The company reported FY24 financial results.
